Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zhimei You"'
Autor:
Danyang Li, Yingcheng Yao, Yuhan Rao, Xinyu Huang, Li Wei, Zhimei You, Guo Zheng, Xiaoli Hou, Yu Su, Zac Varghese, John F. Moorhead, Yaxi Chen, Xiong Z. Ruan
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-16 (2022)
Abstract Background Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the fourth leading cause of cancer-related death worldwide. Sorafenib is currently acknowledged as a standard therapy for advanced HCC. However, acquired resis
Externí odkaz:
https://doaj.org/article/4d096acd33df4c7fb0aa92a63802327f
Autor:
Qing-Qiang Shi, Zi-Qiang Feng, Jing Li, Lv-Cui Zhao, Danyang Li, Guowei Zuo, Jing Xia, Lian Luo, Di-Long Chen, Zhimei You
Publikováno v:
Molecular Medicine Reports
In previous experiments, ginsenoside Rh2 induced apoptosis and cell cycle arrest, which indicates a potential role for ginsenoside Rh2 in anticancer treatment. The effect of ginsenoside Rh2 on cancer is marked and ginsenoside Rh2 has been shown to in
Autor:
Di-Long Chen, Lian Luo, Guowei Zuo, Zhimei You, Qing-Qiang Shi, Jing Li, Zi-Qiang Feng, Jing Xia, Dang-Yang Li, Lv-Cui Zhao
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 15(18)
Purpose: To investigate the effect of deacetylase inhibitory trichostatin A (TSA) on anti HepG2 liver carcinoma cells and explore the underlying mechanisms. Materials and Methods: HepG2 cells exposed to different concentrations of TSA for 24, 48, or
Autor:
Jing, Xia, Dilong, Chen, Guowei, Zuo, Qiang, Wei, Zhimei, You, Danyang, Li, Zehong, Liu, Jing, Li
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 30(10)
To investigate the effects of the 20(S)-ginsenoside Rh2 [Rh2(S)]on cell proliferation, histone deacetylase 1 (HDAC1) and HDAC2 activity, and expression of cyclin in human erythroleukemia K562 cells.The K562 cells were treated with Rh2(S) at various c
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 30(8)
To investigate the combined effect of evodiamine (EVO) and norcantharidin (NCTD) on HepG2 cells.HepG2 cells were treated with EVO or/and NCTD at different concentrations in vitro, with blank culture medium as the negative control. The inhibitory effe
Autor:
Qingqiang, Shi, Guowei, Zuo, Ziqiang, Feng, Lücui, Zhao, Nian, Luo, Zhimei, You, Jing, Xia, Danyang, Li, Jing, Li, Dilong, Chen
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 34(7)
To investigate the inhibitory effect of trichostatin A (TSA) on the proliferation of HepG2 cells and explore the underlying mechanism.HepG2 cells exposed to different concentrations of TSA for 24, 48, or 72 h were examined for cell growth inhibition
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 30(6)
To investigate the effect of ginsenoside Rh2 on leukemia KG1-α cells.KG1-α cells were cultured in 96-well plate and harvested in the exponential phase. The cells were induced in the presence of different concentrations of Rg1, Rb1, Rh2 respectively
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 15(6)
Ginsenoside Rg1 is one effective anticancer and antioxidant constituent of total saponins of Panax ginseng (TSPG), which has been shown to have various pharmacological effects. Our previous study demonstrated that Rg1 had anti-tumor activity in K562
Autor:
QINGQIANG SHI, JING LI, ZIQIANG FENG, LVCUI ZHAO, LIAN LUO, ZHIMEI YOU, DANYANG LI, JING XIA, GUOWEI ZUO, DILONG CHEN
Publikováno v:
Molecular Medicine Reports; 2014, Vol. 10 Issue 4, p1779-1785, 7p